SCHEMBL295490

SCHEMBL295490

CCCCCN[C]=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL511635 0.97
SCHEMBL1792791 0.97 EPHX1 (0.48)
SCHEMBL1794385 0.97 EPHX1 (0.48)
SCHEMBL511816 0.92
SCHEMBL295144 0.79
SCHEMBL44307 0.72
SCHEMBL293422 0.72
SCHEMBL5537085 0.72
SCHEMBL27383471 0.72
SCHEMBL9581730 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169662-B1 SUBSTITUTED VINYL- AND ALKINYL-CYANOCYCLOALKANOLS AND VINYL- AND ALKINYL-CYANOHETEROCYCLOALKANOLS AS AGENTS TO COMBAT ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2018-07-11 EP claimed
EP-1846415-B1 HETEROCYCLIC TETRACYCLIC TETRAHYDROFURAN DERIVATIVES AS 5HT2 INHIBITORS IN THE TREATMENT OF CNS DISORDERS JANSSEN PHARMACEUTICA NV (BE) 2012-08-01 EP claimed
CN-101184759-A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament JANSSEN PHARMACEUTICA NV (BE) 2008-05-21 CN claimed
CN-101115719-A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives JANSSEN PHARMACEUTICA NV (BE) 2008-01-30 CN claimed
CN-101107254-A Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of central nervous system disorders JANSSEN PHARMACEUTICA NV (BE) 2008-01-16 CN claimed
CN-1972949-A Novel unsaturated tetracyclic tetrahydrofuran derivatives JANSSEN PHARMACEUTICA NV (BE) 2007-05-30 CN claimed
CN-118354782-A Compositions comprising peptide compounds for use in combination with surfactants 中外制药株式会社 2024-07-16 CN disclosed
CN-110799520-B Method for synthesizing peptides containing N-substituted amino acids 中外制药株式会社 2024-07-12 CN disclosed
CN-118256591-A Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-06-28 CN disclosed
CN-118184532-A Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same 中外制药株式会社 2024-06-14 CN disclosed
CN-111479819-B Method for preparing peptide and method for treating alkali 中外制药株式会社 2024-06-14 CN disclosed
CN-118176012-A Compositions comprising a peptide compound and a surfactant 中外制药株式会社 2024-06-11 CN disclosed
CN-118076120-A Perovskite solar cell and preparation method thereof 桂林电子科技大学 2024-05-24 CN disclosed
EP-1790639-A1 COMPOUND CONTAINING BASIC GROUP AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-30 EP disclosed
EP-1773797-A2 AROMATIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-04-18 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
WO-2006014012-A2 AROMATIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-02-09 WO disclosed
EP-0628035-A4 RETROVIRAL PROTEASE INHIBITORS. SMITHKLINE BEECHAM CORP (US) 1995-03-29 EP disclosed
EP-0628035-A1 RETROVIRAL PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1994-12-14 EP disclosed
WO-1993017003-A1 RETROVIRAL PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1993-09-02 WO disclosed